BeOne, Hengrui top list of China’s most powerful drugmakers

A new STAT-WireScreen index ranks China's most valuable publicly traded biotech companies. See which one topped the list.
This is a brief. The reporting belongs to STAT — read the complete story, with full context and credits, at the source.
Read the full story at STAT ↗statnews.com
More from the Health desk
Just in

STAT+: Versant, Lilly put $100 million behind new startup aimed at solving one of gene therapy’s thorniest issues
Just in

Why sleep matters when it comes to weight gain and loss
